We are live on ! Find out more
GWP

Gen-Wealth Partners Portfolio holdings

AUM $360M
1-Year Est. Return 27.44%
This Fund
S&P 500
This Quarter Est. Return
+8.49%
1 Year Est. Return
+27.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$229M
AUM Growth
+$22M
Cap. Flow
+$11.8M
Cap. Flow %
5.16%
Top 10 Hldgs %
28.24%
Holding
730
New
83
Increased
194
Reduced
168
Closed
71

Top Buys

Rank Stock Value
1
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$2.62M
2
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$1.68M
3
SMCI icon
Super Micro Computer
SMCI
+$1.29M
4
LRCX icon
Lam Research
LRCX
+$802K
5
EMXC icon
iShares MSCI Emerging Markets ex China ETF
EMXC
+$780K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$825K
2
HEFA icon
iShares Currency Hedged MSCI EAFE ETF
HEFA
+$793K
3
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$597K
4
T icon
AT&T
T
+$507K
5
CLX icon
Clorox
CLX
+$315K

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.23%
2 Technology 9.84%
3 Industrials 9.17%
4 Consumer Staples 8.52%
5 Financials 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDIT icon
651
Editas Medicine
EDIT
$428M
$160 ﹤0.01%
53
– –
CELH icon
652
Celsius Holdings
CELH
$7.18B
$153 ﹤0.01%
+5
New +$210
PACB icon
653
Pacific Biosciences
PACB
$423M
$151 ﹤0.01%
70
– –
ASIX icon
654
AdvanSix
ASIX
$439M
$114 ﹤0.01%
4
– –
VLTO icon
655
Veralto
VLTO
$23.1B
$103 ﹤0.01%
1
– –
GTX icon
656
Garrett Motion
GTX
$4.87B
$78 ﹤0.01%
10
– –
DNA icon
657
Ginkgo Bioworks
DNA
$510M
$39 ﹤0.01%
5
-1
-17% -$10
GRAL
658
GRAIL Inc
GRAL
$3.61B
$14 ﹤0.01%
1
– –
ASPN icon
659
Aspen Aerogels
ASPN
$411M
– –
-2,745
Closed -$65.5K
AXS icon
660
AXIS Capital
AXS
$7.24B
– –
-75
Closed -$5.3K
BALL icon
661
Ball Corp
BALL
$16.1B
– –
-42
Closed -$2.49K
BCYC
662
Bicycle Therapeutics
BCYC
$257M
– –
-39
Closed -$789
BKD icon
663
Brookdale Senior Living
BKD
$2.74B
– –
-100
Closed -$683
BKNG icon
664
Booking.com
BKNG
$127B
– –
-825
Closed -$131K
BLBD icon
665
Blue Bird Corp
BLBD
$1.91B
– –
-2,210
Closed -$109K
BLD
666
DELISTED
TopBuild
BLD
– –
-372
Closed -$150K
BSX icon
667
Boston Scientific
BSX
$62.9B
– –
-1,055
Closed -$81.2K
CAMT icon
668
Camtek
CAMT
$6.75B
– –
-675
Closed -$84.5K
CANG
669
Cango Inc
CANG
$104M
– –
-300
Closed -$5.01K
CHPT icon
670
ChargePoint
CHPT
$273M
– –
-5
Closed -$151
CPRT icon
671
Copart
CPRT
$27.2B
– –
-2,229
Closed -$121K
CRON
672
Cronos Group
CRON
$1.25B
– –
-370
Closed -$862
CRWD icon
673
CrowdStrike
CRWD
$244B
– –
-1,620
Closed -$115K
CSL icon
674
Carlisle Companies
CSL
$12.5B
– –
-175
Closed -$72.4K
CTSH icon
675
Cognizant
CTSH
$27.2B
– –
-3,091
Closed -$210K
25 26
27
28 29

Similar funds

PCA
PL Capital Advisors Naples, Florida $360M AUM 32.54% 1-Year Est. Return
BCM
Barometer Capital Management Toronto, Ontario, Canada $360M AUM 83.37% 1-Year Est. Return
BWIA
Bryant Woods Investment Advisors Getzville, New York $360M AUM 25.8% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $360M AUM 28.63% 1-Year Est. Return
HIS
Horizon Investment Services Hammond, Indiana $360M AUM 80.67% 1-Year Est. Return
MS
Madden Securities Dallas, Texas $360M AUM 16.47% 1-Year Est. Return
MFA
Morling Financial Advisors Fremont, California $360M AUM 17.03% 1-Year Est. Return
MIPU
Man Investment Partners (US) New York $359M AUM

Gen-Wealth Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Gen-Wealth Partners held 730 positions worth $229M, up 11% from $207M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gen-Wealth Partners deployed $11.8M of net new capital in Q3 2024, opening 83 new positions and adding to 194 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1 share worth $683K.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was 3M, an estimated $825K trimmed.

  • Gen-Wealth Partners's largest Q3 2024 buy was Berkshire Hathaway Class A: 1 share worth $683K.
  • Gen-Wealth Partners added most to iShares MSCI EAFE Value ETF in Q3 2024, an estimated $2.62M increase.
  • Gen-Wealth Partners's biggest Q3 2024 reduction was 3M, cutting an estimated $825K.
  • Gen-Wealth Partners fully exited Edwards Lifesciences in Q3 2024, selling an estimated $239K.
  • Gen-Wealth Partners's ten largest holdings make up 28% of its $229M portfolio in Q3 2024.
  • Gen-Wealth Partners opened 83 new positions and closed 71 in Q3 2024.
  • Gen-Wealth Partners's portfolio value rose 11% quarter-over-quarter to $229M.

Based on Gen-Wealth Partners's 13F filing for Q3 2024, filed 13 Nov 2024.